EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients

Lydia Belinger iD, Flora Moujaes, Robin von Rotz, Nathalie M Rieser, Xaver Funk, Klemens Egger iD, Lena Meinhold iD, Maike Renkert iD, Philipp Stämpfli, Marcus Herdener, Franz X Vollenweider, Katrin H Preller

Philosophical Transactions of the Royal Society B: Biological Sciences · 10.11.2026 · 381 (1962)

DOI: 10.1098/rstb.2025.0168 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Philosophical Transactions of the Royal Society B: Biological Sciences, online erschienen am 10.11.2026. Verfasst von Lydia Belinger und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Adult Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich , Zürich, Switzerland. Hauptthemen laut MEDLINE: Psilocybin, Self Concept, Hallucinogens, Major Depressive Disorder. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation (SNSF), Heffter Research Institute, Swiss Neuromatrix Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychedelic-assisted therapy, particularly with psilocybin, is increasingly proposed as a treatment for major depressive disorder, yet the neural and psychological mechanisms underlying its effects remain under investigation. In a randomized, double-blind, placebo-controlled clinical trial, individuals diagnosed with major depressive disorder received a single, moderate dose of psilocybin (0.215 mg kg−1) or placebo, with the same psychological support. We analysed N = 37 individuals with major depressive disorder undergoing assessments of depressive symptoms (Beck's depression inventory and Montgomery–Åsberg depression rating scale), self-concept (Frankfurt self-concept scale) and neural markers of self-referential processing using an fMRI-based task. Compared with placebo, the psilocybin group exhibited significant reductions in depressive symptoms and a significant increase in positive self-concept two weeks after substance administration. Changes in self-concept were significantly correlated with decreased depressive scores. Neuroimaging revealed psilocybin-associated modulation of caudate activation during externally oriented attention after two weeks, contrasting with placebo-induced caudate changes during self-referential processing. These findings extend prior evidence linking psychedelics to changes in self-referential processing and self-concept and demonstrate that such changes occur concurrently with reductions in depressive symptoms. Future research should aim to replicate and extend these results and refine therapy protocols targeting self-processing and self-concept in psychedelic-assisted therapy in major depressive disorder. This article is part of the discussion meeting issue ‘From being to identity: analysis and synthesis of the self’.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsilocybinSelf ConceptHallucinogensMajor Depressive DisorderCognitionHumansDouble-Blind MethodMagnetic Resonance ImagingFemaleMaleAdultMiddle Aged

Stichwörter der Autor:innen

depressionpsilocybinpsychedelic-assisted therapyself-conceptself-referential processing

Substanzen

PsilocybinHallucinogens

Autor:innen und Institutionen

  • Department of Adult Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich , Zürich, Switzerland.
  • Leiden University Institute of Psychology , Leiden, The Netherlands.
  • Neuroscience Center Zurich , Zürich, Switzerland.
  • University Children's Hospital Zürich Center for MR Research , Zürich, Switzerland.
  • Zurich Center for Neuroeconomics, University of Zurich , Zürich, Switzerland.
  • Magnetic Resonance Center, Psychiatric University Hospital Zurich , Zürich, Switzerland.

ORCID-Profile: Lydia Belinger, Klemens Egger, Lena Meinhold, Maike Renkert

Förderung

  • Swiss National Science Foundation (SNSF)
  • Heffter Research Institute
  • Swiss Neuromatrix Foundation

Zitieren

APA

Belinger, L., Moujaes, F., von Rotz, R., Rieser, N. M., Funk, X., Egger, K., Meinhold, L., Renkert, M., Stämpfli, P., Herdener, M., Vollenweider, F. X., & Preller, K. H. (2026). Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients. Philosophical Transactions of the Royal Society B: Biological Sciences, 381(1962). https://doi.org/10.1098/rstb.2025.0168

Vancouver

Belinger L, Moujaes F, von Rotz R, Rieser NM, Funk X, Egger K, et al. Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients. Philosophical Transactions of the Royal Society B: Biological Sciences. 2026;381(1962). doi:10.1098/rstb.2025.0168

BibTeX
@article{Belinger2026,
  author = {Belinger, Lydia and Moujaes, Flora and von Rotz, Robin and Rieser, Nathalie M and Funk, Xaver and Egger, Klemens and Meinhold, Lena and Renkert, Maike and Stämpfli, Philipp and Herdener, Marcus and Vollenweider, Franz X and Preller, Katrin H},
  title = {Changes in self-related cognitive processes and depressive symptom severity following a single, moderate dose of psilocybin in depressed patients},
  journal = {Philosophical Transactions of the Royal Society B: Biological Sciences},
  year = {2026},
  volume = {381},
  number = {1962},
  doi = {10.1098/rstb.2025.0168}
}
Kostenlos starten →